← Leaderboards
Nicholas C Denko
Ohio State University
$10,501,039
Attributed
$14,555,539
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,555,539 · 12
By mechanism
R01$10,161,272 · 5
P01$2,957,633 · 4
R21$836,916 · 2
S10$599,718 · 1
Top collaborators
- Zihai Li12 shared
- Terence Marques Williams7 shared
- Daniel T. Chang2 shared
Most similar at Ohio State University
Same institution · by research overlap
- Zihai Li$25,199,729
- Yang Liu$21,443,530
- Susan R Mallery$15,292,540
- Martin Benej$524,296
Others in their field
Top investigators on “Hypoxia”
- James B Edson · Woods Hole Oceanographic Institution$110,367,520
- Albert J Plueddemann · Woods Hole Oceanographic Institution$110,367,520
- David Heimbrook · Leidos Biomedical Research, Inc.$41,862,534
- Nanduri R Prabhakar · Case Western Reserve University$32,967,177
- Zaver M Bhujwalla · Johns Hopkins University$30,055,665
- Donna M. Ferriero · University Of California, San Francisco$27,259,560
Research focus
HypoxiaNeoplastic CellTumorMitochondriaPharmaceutical PreparationsOxygen ConsumptionDoseCellsOxygenNormal Tissue MorphologyResponseMalignant NeoplasmsRadiation TherapyMetabolicRadiationIn VivoRadiosensitizationClinical TrialsImageComplexImmuneMetabolismEquilibriumDesign
Grant awards (46)
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism$640,703
R01 · FY2025 · CA · contact PI
Overcoming hypoxic resistance to anti-cancer therapy$582,714
R01 · FY2025 · CA · contact PI
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism$608,669
R01 · FY2024 · CA · contact PI
Overcoming hypoxic resistance to anti-cancer therapy$553,580
R01 · FY2024 · CA · contact PI
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism$627,890
R01 · FY2023 · CA · contact PI
Overcoming hypoxic resistance to anti-cancer therapy$571,062
R01 · FY2023 · CA · contact PI
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism$212,016
R01 · FY2023 · CA · contact PI
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism$632,109
R01 · FY2022 · CA · contact PI
Overcoming hypoxic resistance to anti-cancer therapy$571,062
R01 · FY2022 · CA · contact PI
Diversity Supplement R01CA262388: Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism$216,344
R01 · FY2022 · CA · contact PI
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism$650,406
R01 · FY2021 · CA · contact PI
Overcoming hypoxic resistance to anti-cancer therapy$582,714
R01 · FY2021 · CA · contact PI
A phase 0 pilot study to determine if papaverine increases oxygenation in spontaneous canine soft tissue sarcoma$169,650
R21 · FY2021 · CA · contact PI
A phase 0 pilot study to determine if papaverine increases oxygenation in spontaneous canine soft tissue sarcoma$203,580
R21 · FY2019 · CA · contact PI
Metabolic Radiosensitization$202,017
P01 · FY2017 · CA · contact PI
Decreasing oxygen metabolism to redcue hypoxia and radiosensitize tumors.$316,438
R01 · FY2016 · CA · contact PI
Metabolic Radiosensitization$202,017
P01 · FY2016 · CA · contact PI
SARRP 200 Small animal radiation research platform$599,718
S10 · FY2015 · OD · contact PI
Decreasing oxygen metabolism to redcue hypoxia and radiosensitize tumors.$316,438
R01 · FY2015 · CA · contact PI
Metabolic Radiosensitization$202,017
P01 · FY2015 · CA · contact PI
Decreasing oxygen metabolism to redcue hypoxia and radiosensitize tumors.$306,945
R01 · FY2014 · CA · contact PI
Metabolic Radiosensitization$195,957
P01 · FY2014 · CA · contact PI
Decreasing oxygen metabolism to redcue hypoxia and radiosensitize tumors.$88,790
R01 · FY2014 · CA · contact PI
Decreasing oxygen metabolism to redcue hypoxia and radiosensitize tumors.$297,452
R01 · FY2013 · CA · contact PI
Metabolic Radiosensitization$202,017
P01 · FY2013 · CA · contact PI
Decreasing oxygen metabolism to redcue hypoxia and radiosensitize tumors.$91,264
R01 · FY2013 · CA · contact PI
Decreasing oxygen metabolism to redcue hypoxia and radiosensitize tumors.$316,438
R01 · FY2012 · CA · contact PI
Visualizing changes in tumor metabolism using fuctional PET imaging$230,343
R21 · FY2012 · CA · contact PI
Hypoxic Regulation of Mitochondrial Function$258,919
P01 · FY2011 · CA · contact PI
Visualizing changes in tumor metabolism using fuctional PET imaging$233,343
R21 · FY2011 · CA · contact PI
Hypoxic Regulation of Mitochondrial Function$284,584
P01 · FY2010 · CA · contact PI
Hypoxic Regulation of Mitochondrial Function$279,005
P01 · FY2009 · CA · contact PI
Hypoxic Regulation of Mitochondrial Function$270,873
P01 · FY2008 · CA · contact PI
Hypoxic Regulation of Mitochondrial Function$266,723
P01 · FY2007 · CA · contact PI
HIG2 and Hypoxic Regulation of Protein Synthesis$238,960
R01 · FY2007 · CA · contact PI
The Role of NC2 in Gene Repression by Tumor Hypoxia$238,952
R01 · FY2007 · CA · contact PI
HIG2 and Hypoxic Regulation of Protein Synthesis$246,097
R01 · FY2006 · CA · contact PI
The Role of NC2 in Gene Repression by Tumor Hypoxia$246,087
R01 · FY2006 · CA · contact PI
HIG2 and Hypoxic Regulation of Protein Synthesis$252,019
R01 · FY2005 · CA
The Role of NC2 in Gene Repression by Tumor Hypoxia$252,010
R01 · FY2005 · CA
HIG2 and Hypoxic Regulation of Protein Synthesis$252,104
R01 · FY2004 · CA
NC2 in Gene Repression by Tumor Hypoxia$252,009
R01 · FY2004 · CA
CORE--STATISTICS AND BIOINFORMATICS$296,752
P01 · FY2002 · CA
CONTRIBUTION OF BNIP3/BNIP3L TO APOPTOSIS$0
P01 · FY2002 · CA
CORE--STATISTICS AND BIOINFORMATICS$296,752
P01 · FY2001 · CA
CONTRIBUTION OF BNIP3/BNIP3L TO APOPTOSIS$0
P01 · FY2001 · CA